Doxorubicin Hydrochloride

• Pressurized intrathoracic aerosol chemotherapy (PITAC) in patients with malignant pleural effusion: a single-center phase II trial. PITAC_ M… Not authorised
  2024-511255-17-00 Phase II 1 country Azienda Ospedaliero Universitaria Pisana
• A prospective, open-label, randomized, multicenter phase-III trial to evaluate the efficacy of pirtobrutinib and epcoritamab compared with R… Pending
  2024-513445-37-00 Phase III 4 countries University Of Cologne
• SIOP PNET 5 medulloblastoma Pending
  2024-513724-42-00 Phase II/III 10 countries University Medical Center Hamburg-Eppendorf
• Dose monitoring of commonly used cytostatic drugs for breast cancer Pending
  2024-514818-12-00 Phase IV 1 country Karolinska Institutet
• Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients … Pending
  2024-517295-37-00 Phase III 1 country University Of Cologne
• Phase II Prospective Multicenter Study of High-Dose Treosulfan/Melphalan as Consolidation Treatment in Newly Diagnosed High-Risk and Very Hi… Pending
  2024-518912-37-01 Phase II 1 country Fondazione Santobono Pausilipon Onlus
• Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( R… Pending
  2024-519818-31-01 Phase III 11 countries Genmab A/S
• PROSPECTIVE, PHASE II STUDY TO EVALUATE THE EFFICACY OF ADDITION OF PROGESTERONE TO STANDARD CHEMOTHERAPY ACCORDING TO EDP SCHEME PLUS MITOT… Pending
  2024-520160-34-00 Phase II 1 country Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
• Phase 3 Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Platinum Resistant Ovarian Cancer With Cyclin E1 Overexpression Pending
  2025-522748-42-00 Phase III 8 countries Incyte Corp.
• Efficacy and Tolerability of N-AVD compared to BrECADD in patients with advanced Hodgkin Lymphoma (N-BRAVE) Pending
  2026-525263-41-00 Phase III 1 country Polska Grupa Badawcza Chloniakow
• A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants with Platinum-Resistant (Part A) and Platinum-Sensitive (Part B… Recruiting
  2025-522255-25-00 Phase III 15 countries Eli Lilly & Co.
• A clinical study of the anti-cancer effects of an investigational therapy or chemotherapy in patients with recurring uterine cancer Recruiting
  2023-507525-42-00 Phase III 15 countries BioNTech SE
• An Open-label, Randomized, Phase 3 Study to Evaluate Patritumab Deruxtecan Monotherapy versus Treatment of Physician’s Choice in Hormone Rec… Recruiting
  2025-520582-51-00 Phase III 7 countries Merck Sharp & Dohme LLC
• Clinical trial that compares MK-2870 with or without pembrolizumab to chemotherapy in people with breast cancer that cannot be surgically re… Recruiting
  2023-504918-29-00 Phase III 16 countries Merck Sharp & Dohme LLC
• Mirvetuximab soravtansine in combination with bevacizumab for the maintenance treatment of adult patients with FRα-high recurrent platinum-s… Recruiting
  2022-501606-35-01 Phase III/IV 11 countries AbbVie Deutschland GmbH & Co. KG
• A trial to learn if odronextamab is safe and well-tolerated and how well it works compared to rituximab combined with different types of che… Recruiting
  2022-502660-20-00 Phase III 8 countries Regeneron Pharmaceuticals Inc.
• A Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors Recruiting
  2023-510275-64-00 Phase I/II 4 countries Eisai Limited
• This study is to find out the safety and effectiveness of Epcoritamab together with R-CHOP (rituximab, cyclophosphamide, doxorubicin HCL, vi… Recruiting
  2023-505277-32-00 Phase III 16 countries AbbVie Deutschland GmbH & Co. KG
• A study to test the effect of chemotherapy before surgery compared to surgery alone in patients with high risk retroperitoneal sarcoma. Recruiting
  2023-505261-84-00 Phase III 10 countries European Organisation For Research And Treatment Of Cancer
• CLINICAL TRIAL TO EVALUATE BLADDER INSTILLATION OF NEOADJUVANT CHEMOTHERAPY TO TRANSURETHRAL RESECTION OF THE BLADDER FOR THE PREVENTION OF … Recruiting
  2024-512683-53-00 Phase IV 1 country Hospital Universitario La Paz
• The Efficacy of Pressurised Intraperitoneal aerosol chemotherapy (PIPAC) combined with CURativE intent minimally invasive radical resection … Recruiting
  2024-516194-76-00 Phase II 3 countries Odense University Hospital
• Serial cardiac magnetic resonance imaging (CMR) with contrast agents and biomarker analysis for the detection of cardiotoxicity under anthr… Recruiting
  2025-521573-14-00 Phase IV 1 country Robert Bosch Gesellschaft fuer medizinische Forschung mbH
• A trial to learn how safe AZD0486 is and how well it works in older or physically weak adults with large B-cell lymphoma when given after R-… Recruiting
  2025-522029-37-00 Phase III 2 countries AstraZeneca AB
• Phase II, multicentre, randomised, open-label trial with MAP +/- denosumab regimen for the treatment of patients with metastatic osteosarcom… Recruiting
  2024-518167-35-01 Phase II 1 country Associazione Italiana Ematologia Oncologia Pediatrica

Showing 1–24 of 104 trials